PROZYME
Prozyme, Inc.
Application Filed: 2018-05-09
Trademark Application Details
REGISTERED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 87914504 |
| Registration Number | 5947276 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Domestic Representative | Ester Martin |
| Attorney Name | Ester Martin |
| Attorney Docket Number | 86719.0765 |
| Law Office Assigned | M80 |
| Employee Name | MEYERS, MORGAN LAURA |
Timeline
| 1990-12-07 | Date of First Use |
| 2018-05-09 | Application Filed |
| 2019-10-15 | Published for Opposition |
| 2019-12-31 | Location: PUBLICATION AND ISSUE SECTION |
| 2019-12-31 | Status: Live/Registered |
| 2019-12-31 | Trademark Registered |
| 2019-12-31 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Prozyme, Inc. |
| Address | 3832 Bay Center Place Hayward CA 94545 |
| Legal Entity Type | Corporation |
| Legal Entity State | CA |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 1 |
| U.S. Codes: | 001,005,006,010,026,046 |
| International Codes: | 9 |
| U.S. Codes: | 021,023,026,036,038 |
| International Codes: | 10 |
| U.S. Codes: | 026,039,044 |
| Type Code | Type |
|---|---|
| GS0011 | Containers, namely cartridges containing prepackaged media, for use for specific analyses used in research in the field of biopharmaceuticals, biochemical scientific research, and clinical diagnostic applications; enzymes for use in the scientific research industry in the field of biopharmaceuticals; analytical reagents, namely, biochemical reagents, reference reagents, fluorescent labeling reagents for use in the scientific research industry in the field of biopharmaceuticals, biochemical scientific research, and clinical diagnostic applications; micro-chromatography columns for use in preparing samples for specific analyses in scientific research in the field of biopharmaceuticals applications, biochemical scientific research, and clinical diagnostic applications; diagnostic kits and reagent kits comprised of cartridges, enzymes, protein preparations, biochemical reagents, fluorescent labeling reagents and micro-chromatography columns for scientific use; enzymes for releasing or digesting the carbohydrate portion from the protein portion of glycoproteins for in vitro laboratory use; purified biochemicals, namely, proteins, enzymes, glycans, protein preparations, biochemical reagents, reference reagents and formulations including proteins and enzymes, fluorescent proteins, fluorescent chemicals and formulations including such proteins and chemicals for use as reagents in the biochemical scientific research and clinical diagnostic applications |
| GS0011 | Containers, namely cartridges containing prepackaged media, for use for specific analyses used in research in the field of biopharmaceuticals, biochemical scientific research, and clinical diagnostic applications; enzymes for use in the scientific research industry in the field of biopharmaceuticals; analytical reagents, namely, biochemical reagents, reference reagents, fluorescent labeling reagents for use in the scientific research industry in the field of biopharmaceuticals, biochemical scientific research, and clinical diagnostic applications; micro-chromatography columns for use in preparing samples for specific analyses in scientific research in the field of biopharmaceuticals applications, biochemical scientific research, and clinical diagnostic applications; diagnostic kits and reagent kits comprised of cartridges, enzymes, protein preparations, biochemical reagents, fluorescent labeling reagents and micro-chromatography columns for scientific use; enzymes for releasing or digesting the carbohydrate portion from the protein portion of glycoproteins for in vitro laboratory use; purified biochemicals, namely, proteins, enzymes, glycans, protein preparations, biochemical reagents, reference reagents and formulations including proteins and enzymes, fluorescent proteins, fluorescent chemicals and formulations including such proteins and chemicals for use as reagents in the biochemical scientific research and clinical diagnostic applications |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2018-05-12 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-05-18 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2018-08-30 | 3 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2018-09-03 | 4 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2018-09-03 | 5 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2018-09-03 | 6 GNRN O:Outgoing Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2018-10-01 | 7 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2018-10-01 | 8 ARAA I:Incoming Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2019-03-03 | 9 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-03-03 | 10 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-03-04 | 11 TEME I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2019-03-03 | 12 TCCA I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2019-03-11 | 13 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2019-03-12 | 14 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2019-03-12 | 15 GNRT O:Outgoing Correspondence |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2019-03-12 | 16 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2019-09-09 | 17 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-09-09 | 18 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-09-09 | 19 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2019-09-10 | 20 CNSA O:Outgoing Correspondence |
| ASSIGNED TO LIE | 2019-09-12 | 21 ALIE A:Allowance for Publication |
| ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | 2019-09-18 | 22 ASCK I:Incoming Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2019-09-25 | 23 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2019-10-15 | 24 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2019-10-15 | 25 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2019-12-31 | 26 R.PR A:Allowance for Publication |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2020-06-08 | 27 COAR I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2020-06-08 | 28 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2020-06-08 | 29 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2020-06-08 | 30 TCCA I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2020-06-08 | 31 CHAN I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2020-08-25 | 32 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2020-08-25 | 33 ARAA I:Incoming Correspondence |
| TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED | 2020-08-25 | 34 EWOR I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2020-08-25 | 35 TCCA I:Incoming Correspondence |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2022-02-23 | 36 COAR I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2022-02-23 | 37 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2022-02-23 | 38 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2022-02-23 | 39 TCCA I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2022-02-23 | 40 CHAN I:Incoming Correspondence |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 